Table S8a: Enrichment of gene ontology (GO) categories for up-regulated genes in A549 cells upon Dex treatment for 24 h. The GO categories are shown for transcripts that were differentially expressed (fold-change >3.0  t-test p value <0.05).

Table S6b: Enrichment of gene ontology (GO) categories for down-regulated genes in A549 cells upon T treatment for 24 h. The GO categories are shown for transcripts that were differentially expressed (fold-change >1.8  t-test p value <0.05).

Table S5b: Down-regulated genes in A549 cells treated with 100 nM T or vehicle for 24 h.

Table S4b:  Down-regulated genes (fold-change >1.8  t-test p-value <0.05) in the lung tissue of intact male and female mice.

Table S2b: Down-regulated genes (fold-change >1.8  t-test p-value <0.05) in murine lung after a five-day T treatment of castrated male mice over those in vehicle-treated animals.

Table 2. Enriched gene ontology (GO) categories between intact male and female mouse lung

Table S4a: Up-regulated genes (fold-change >1.8  t-test p-value <0.05) in the lung tissue of intact male and female mice.

Table 1. Enriched gene ontology (GO) categories in murine lung upon T treatment

Table S2a:Up-regulated genes (fold-change >1.8  t-test p-value <0.05) in murine lung after a five-day T treatment of castrated male mice over those in vehicle-treated animals.

Figure 1A. cDNA microarray expression of osteogenic genes in epithelial and stromal cells: POSTN vs high grade TA stromal cells

Figure 1B. cDNA microarray expression of osteogenic genes in epithelial and stromal cells: POSTN vs high grade tumor epithelial cells

Figure 1C. cDNA microarray expression of osteogenic genes in epithelial and stromal cells: POSTN vs low grade TA stromal cells

Figure 1D. cDNA microarray expression of osteogenic genes in epithelial and stromal cells: POSTN vs low grade tumor epithelial cells

Table 3. PK genes highly and specifically expressed in CLL.

Table A3. List of 82 Affymetrix Probe Sets That Are Differentially Expressed in Patients With CN-AML With biCEBPA Mutations Compared With Patients With moCEBPA Mutation  Ordered by the Fold Change Between Patients With biCEBPA and moCEBPA